{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:05:54Z","timestamp":1791295554844,"version":"4.1.0"},"reference-count":84,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:00:00Z","timestamp":1491868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI081886"],"award-info":[{"award-number":["R01 AI081886"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI081084"],"award-info":[{"award-number":["R21 AI081084"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The 17D line of yellow fever virus vaccines is among the most effective vaccines ever created. The humoral and cellular immunity elicited by 17D has been well characterized in humans. Neutralizing antibodies have long been known to provide protection against challenge with a wild-type virus. However, a well characterized T cell immune response that is robust, long-lived and polyfunctional is also elicited by 17D. It remains unclear whether this arm of immunity is protective following challenge with a wild-type virus. Here we introduce the 17D line of yellow fever virus vaccines, describe the current state of knowledge regarding the immunity directed towards the vaccines in humans and conclude with a discussion of animal models that are useful for evaluating T cell-mediated immune protection to yellow fever virus.<\/jats:p>","DOI":"10.3390\/v9040077","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T11:41:42Z","timestamp":1491910902000},"page":"77","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-8296","authenticated-orcid":false,"given":"Alan","family":"Watson","sequence":"first","affiliation":[{"name":"Center for Vaccine Research, Departments of Microbiology and Molecular Genetics, and Immunology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Klimstra","sequence":"additional","affiliation":[{"name":"Center for Vaccine Research, Departments of Microbiology and Molecular Genetics, and Immunology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"ref_1","unstructured":"Plotkin, S.A., Orenstein, W.A., and Offit, P.A. (2012). Yellow fever vaccine. Vaccines, Saunders Elsevier."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bryant, J.E., Holmes, E.C., and Barrett, A.D.T. (2007). Out of Africa: A molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030075"},{"key":"ref_3","first-page":"37","article-title":"The etiology of yellow fever\u2014A preliminary note","volume":"26","author":"Reed","year":"1900","journal-title":"Public Health Pap. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1201-9712(97)90015-1","article-title":"Experimental transmission of yellow fever virus to laboratory animals","volume":"2","author":"Stokes","year":"1997","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.1928.02690310005002","article-title":"The Transmission of yellow fever to Macacus rhesus: Preliminary note","volume":"90","author":"Stokes","year":"1928","journal-title":"J. Am. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00034983.1930.11684639","article-title":"Studies on the action of yellow fever virus in mice","volume":"24","author":"Theiler","year":"1930","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.17.6.339","article-title":"The behavior of the virus of yellow fever in monkeys and mice","volume":"17","author":"Sellards","year":"1931","journal-title":"PNAS"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.65.6.767","article-title":"The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus","volume":"65","author":"Theiler","year":"1937","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The Use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20072290","article-title":"Yellow fever and Max Theiler: The only Nobel Prize for a virus vaccine","volume":"204","author":"Norrby","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_11","first-page":"77","article-title":"The yellow fever vaccine: A history","volume":"83","author":"Frierson","year":"2010","journal-title":"Yale J. Biol. Med."},{"key":"ref_12","unstructured":"World Health Organization, Division of Epidemiological Surveillance and Health Situation Trend Assessment (1992). Global Health Situation and Projections\u2014Estimates, World Health Organization."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jrid.2016.07.007","article-title":"Six cases of imported yellow fever in China: 12 March 2016\u201324 March 2016","volume":"3","author":"Li","year":"2016","journal-title":"Radiol. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2016.04.025","article-title":"Yellow fever cases in Asia: Primed for an epidemic","volume":"48","author":"Wasserman","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Monaghan, A.J., Morin, C.W., Steinhoff, D.F., Wilhelmi, O., Hayden, M., Quattrochi, D.A., Reiskind, M., Lloyd, A.L., Smith, K., and Schmidt, C.A. (2016). On the seasonal occurrence and abundance of the Zika virus vector mosquito Aedes aegypti in the contiguous United States. PLoS Curr.","DOI":"10.1371\/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in Flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: Protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant yellow fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","article-title":"Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development","volume":"28","author":"Franco","year":"2010","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2010.04.071","article-title":"Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii","volume":"28","author":"Stoyanov","year":"2010","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nogueira, R.T., Nogueira, A.R., Pereira, M.C.S., Rodrigues, M.M., Neves, P.C.D.C., Galler, R., and Bonaldo, M.C. (2013). Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi. PLoS ONE, 8.","DOI":"10.1371\/annotation\/39b41d98-b117-41cf-b5de-b8486a67b1cd"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","article-title":"Recombinant, chimaeric live, attenuated vaccine (ChimeriVaxTM) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: Innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.vaccine.2011.04.055","article-title":"Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review","volume":"29","author":"Thomas","year":"2011","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2010.10.015","article-title":"Is it time for a new yellow fever vaccine?","volume":"28","author":"Hayes","year":"2010","journal-title":"Vaccine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00034983.1928.11684585","article-title":"The immunological relationship of yellow fever as it occurs in West Africa and in South America","volume":"22","author":"Theiler","year":"1928","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: Systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human Flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J. Med. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: Neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop. Med. Int. Health"},{"key":"ref_32","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wieten, R.W., Jonker, E.F.F., Leeuwen, E.M.M.V., Remmerswaal, E.B.M., Berge, I.J.M.T., Visser, A.W.D., Genderen, P.J.J.V., Goorhuis, A., Visser, L.G., and Grobusch, M.P. (2016). A Single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149871"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13149-011-0135-7","article-title":"Persistance \u00e0 long terme des anticorps neutralisants de la fi\u00e8vre jaune chez les personnes \u00e2g\u00e9es de 60 ans et plus","volume":"104","author":"Bodilis","year":"2011","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with the 17D yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"TLR expression and NK cell activation after human yellow fever vaccination","volume":"27","author":"Marcovistz","year":"2009","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/jir439","article-title":"Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody","volume":"204","author":"Batista","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.vaccine.2010.08.046","article-title":"Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults","volume":"29","author":"Silva","year":"2011","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Longman","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1073\/pnas.1500475112","article-title":"Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination","volume":"112","author":"Akondy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/eji.201142306","article-title":"The early cellular signatures of protective immunity induced by live viral vaccination","volume":"42","author":"Kohler","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.4049\/jimmunol.1202234","article-title":"Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response","volume":"190","author":"Blom","year":"2013","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1128\/JVI.01160-13","article-title":"Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins","volume":"87","author":"James","year":"2013","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: Is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1128\/JVI.03474-14","article-title":"Dynamics of the cytotoxic T cell response to a model of acute viral infection","volume":"89","author":"DeWitt","year":"2015","journal-title":"J. Virol."},{"key":"ref_52","first-page":"282ra48","article-title":"Long-lasting stem cell\u2013like memory CD8+ T cells with a na\u00efve-like profile upon yellow fever vaccination","volume":"7","author":"Marraco","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Campi-Azevedo, A.C., Ara\u00fajo-Porto, L.P.D., Luiza-Silva, M., Batista, M.A., Martins, M.A., Sathler-Avelar, R., da Silveira-Lemos, D., Camacho, L.A.B., de Menezes Martins, R., and de Lourdes de Sousa Maia, M. (2012). 17DD and 17D-213\/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049828"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Ann. Rev. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4+ T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T cells complement antibodies in protecting against yellow fever virus","volume":"194","author":"Bassi","year":"2015","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"Sakho","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","article-title":"Revisiting the liver in human yellow fever: Virus-induced apoptosis in hepatocytes associated with TGF-\u03b2, TNF-\u03b1 and NK cells activity","volume":"345","author":"Quaresma","year":"2006","journal-title":"Virology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trstmh.2006.02.019","article-title":"Hepatocyte lesions and cellular immune response in yellow fever infection","volume":"101","author":"Quaresma","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mehy.2006.01.060","article-title":"Midzonal lesions in yellow fever: A specific pattern of liver injury caused by direct virus action and in situ inflammatory response","volume":"67","author":"Quaresma","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","article-title":"Yellow fever vaccine: Direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 Gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00251-010-0461-0","article-title":"The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques\u2014Implications for recombinant vaccine design","volume":"62","author":"Mudd","year":"2010","journal-title":"Immunogenetics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1016\/j.vaccine.2010.09.090","article-title":"CD8+ \u03b3\u03b4 TCR+ and CD4+ T cells produce IFN-\u03b3 at 5\u20137 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses","volume":"28","author":"Neves","year":"2010","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Meier, K.C., Gardner, C.L., Khoretonenko, M.V., Klimstra, W.B., and Ryman, K.D. (2009). A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000614"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Watson, A.M., Lam, L.K.M., Klimstra, W.B., and Ryman, K.D. (2016). The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005786"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JVI.75.5.2107-2118.2001","article-title":"Yellow fever virus encephalitis: Properties of the brain-associated T-cell response during virus clearance in normal and \u03b3 interferon-deficient mice and requirement for CD4+ lymphocytes","volume":"75","author":"Liu","year":"2001","journal-title":"J. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/viro.2002.1432","article-title":"Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice","volume":"296","author":"Vandermost","year":"2002","journal-title":"Virology"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bassi, M.R., Larsen, M.A.B., Kongsgaard, M., Rasmussen, M., Buus, S., Stryhn, A., Thomsen, A.R., and Christensen, J.P. (2016). Vaccination with replication deficient adenovectors encoding YF-17D antigens induces long-lasting protection from severe yellow fever virus infection in mice. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004464"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1099\/0022-1317-67-4-631","article-title":"Comparison of neurovirulence of different strains of yellow fever virus in mice","volume":"67","author":"Barrett","year":"1986","journal-title":"J. Gen. Virol."},{"key":"ref_72","unstructured":"Watson, A.M., Lam, L.K.M., and Klimstra, W.B. CD8+ T cells are Required for the Control of the Live Attenuated 17D-204 Yellow Fever Vaccine, Manuscript under preparation."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2006.07.001","article-title":"Inflaming the CD8+ T cell response","volume":"25","author":"Haring","year":"2006","journal-title":"Immunity"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.177.3.1746","article-title":"Innate inflammatory signals induced by various pathogens ddifferentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation","volume":"177","author":"Thompson","year":"2006","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4269\/ajtmh.2007.76.144","article-title":"Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1\u20134","volume":"76","author":"Deauvieau","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1590\/S0074-02762011000500012","article-title":"dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-\u03b1 and IFN-\u03b1 profiles","volume":"106","author":"Gandini","year":"2011","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.1001191","article-title":"Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host","volume":"186","author":"Mandl","year":"2011","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"ra25","DOI":"10.1126\/scisignal.aaa1552","article-title":"Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons","volume":"8","author":"Bruni","year":"2015","journal-title":"Sci. Signal."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.vaccine.2012.03.003","article-title":"A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain","volume":"30","author":"Thibodeaux","year":"2012","journal-title":"Vaccine"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chen, K., Liu, J., and Cao, X. (2017). Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review. J. Autoimmun.","DOI":"10.1016\/j.jaut.2017.03.008"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1471-4906(01)02118-4","article-title":"STAT1-dependent and -independent pathways in IFN-\u03b3-dependent signaling","volume":"23","author":"Ramana","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1038\/ncomms14781","article-title":"Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome","volume":"8","author":"Douam","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Greene, J.M., Burwitz, B.J., Blasky, A.J., Mattila, T.L., Hong, J.J., Rakasz, E.G., Wiseman, R.W., Hasenkrug, K.J., Skinner, P.J., and O\u2019Connor, S.L. (2008). Allogeneic lymphocytes persist and traffic in feral MHC-matched Mauritian cynomolgus macaques. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002384"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1073\/pnas.0607426104","article-title":"Germ-line chimerism and paternal care in marmosets (Callithrix kuhlii)","volume":"104","author":"Ross","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/4\/77\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:32:25Z","timestamp":1760207545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/4\/77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"alternative-id":["v9040077"],"URL":"https:\/\/doi.org\/10.3390\/v9040077","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]}}}